TC BioPharm (Holdings) plc - Warrants (TCBPW)

Last Price0.0060

Change+0.00 (0.00%)

NASDAQ · Last Trade: Apr 5th, 11:49 PM EDT

TC BioPharm Doses First 3 Patients in Phase 2b Clinical Trial of Lead Compound, OmnImmune®, To Treat Acute Myeloid Leukemiabenzinga.com

TC Biopharm (NASDAQ: TCBP) (NASDAQ: TCBPW) recently announced the dosing of its first three patients within its Phase 2b clinical trial of OmnImmune®,

Via Benzinga · November 22, 2022